Clinical Study

Long-Term Prospective Study of the Influence of Estrone Levels on Events in Postmenopausal Women with or at High Risk for Coronary Artery Disease

Table 3

Baseline clinical characteristics and comparison of 246 patients by survival status (32 deaths).

Alive ( 𝑁 = 2 1 4 ) Death ( 𝑁 = 3 2 ) 𝑃

Age (years) 6 9 . 2 ± 6 . 9 7 2 . 6 ± 7 . 2 0.010
Body mass index 2 9 . 7 ± 5 . 2 2 8 . 3 ± 5 . 7 0.157
Hypertension205 (96)28 (88)0.051
Diabetes93 (43)13 (41)0.763
Dyslipidemia200 (93)28 (88)0.227
Coronary artery disease54 (25)6 (19)0.426
Family history151 (71)19 (59)0.202
Smoking23 (11)2 (6)0.432
SBP (mm Hg) 1 4 1 . 4 ± 1 8 . 2 1 4 3 . 1 ± 1 9 . 7 0.612
DBP (mm Hg) 8 2 . 9 ± 9 . 8 8 2 . 8 ± 1 0 . 2 0.938
Triglycerides (mg/dL) 1 7 2 . 2 ± 1 1 9 1 7 0 . 6 ± 1 0 1 0.908
Total cholesterol (mg/dL) 1 9 8 . 4 ± 4 1 . 9 2 0 4 ± 3 3 . 9 0.468
HDL cholesterol (mg/dL) 5 3 . 3 ± 1 2 . 8 5 0 . 6 ± 1 0 . 7 0.251
LDL cholesterol (mg/dL) 1 1 1 . 2 ± 3 7 . 1 1 2 1 . 3 ± 2 5 . 2 0.054
Glucose (mg/dL) 1 3 2 . 6 ± 5 6 . 4 1 3 1 . 3 ± 6 4 . 5 0.904
C reactive protein (mg/dL) 0 . 6 2 ± 1 . 0 4 0 . 8 5 ± 2 . 1 2 0.548
Estrone (pg/mL) 2 5 . 1 ± 1 3 . 6 2 1 . 6 ± 1 1 . 5 0.166

SBP: systolic blood pressure; DBP: diastolic blood pressure.